Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microchip Biotechnologies Inc. was a life science tools company that developed automated microfluidic systems for genomic analysis and sample preparation. Founded in 2003, the company specialized in 'lab-on-a-chip' technologies that integrated complex biochemical workflows onto small, disposable cartridges. Their primary products, including the Apollo 100 system, were designed to automate DNA sequencing preparation and forensic human identification for the research, biodefense, and clinical markets. The company's technology was aimed at reducing the time, cost, and manual labor associated with high-throughput genetic testing. In 2011, Microchip Biotechnologies was acquired by IntegenX to strengthen its portfolio of rapid DNA identification solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microchip Biotechnologies.